Jeffrey David Jones
Known title: DirectorCIK: 0001503030
Associated companies
Transaction History
| VC | ▲ Buy | Option Exercise | 1,829 | — | 6/5/2026 | View on chart |
| VC | ▲ Buy | Option Exercise | 1,396 | — | 6/6/2025 | View on chart |
| VC | ▼ Sell | Open Market | 200 | $19K | 8/16/2024 | View on chart |
| VC | ▼ Sell | Open Market | 100 | $10K | 8/16/2024 | View on chart |
| VC | ▼ Sell | Open Market | 401 | $39K | 8/16/2024 | View on chart |
| VC | ▲ Buy | Option Exercise | 841 | — | 6/8/2024 | View on chart |
| VC | ▼ Sell | Open Market | 1,000 | $115K | 2/23/2024 | View on chart |
| VC | ▲ Buy | Option Exercise | 1,189 | — | 6/23/2023 | View on chart |
| VC | ▲ Buy | Option Exercise | 1,003 | — | 6/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Visteon faces price target cuts from Barclays, UBS, and Goldman Sachs
Three major banks recently lowered their price targets for Visteon, with Barclays cutting to $125, UBS to $107, and Goldman Sachs to $104. Despite these reductions, all three firms maintained their positive ratings on the stock. The moves come as the stock trades near its 52-week low, reflecting broader caution in the automotive supplier sector.
Visteon faces price target cuts from Barclays, UBS, and Goldman Sachs. Three major banks recently lowered their price targets for Visteon, with Barclays cutting to $125, UBS to $107, and Goldman Sachs to $104. Despite these reductions, all three firms maintained their positive ratings on the stock. The moves come as the stock trades near its 52-week low, reflecting broader caution in the automotive supplier sector.